Lcmc3
Research payments
$5,021,840
Through program year 2024, $5,021,840 in research payments was reported against Lcmc3, across 661 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $1,242,168 | 91 |
| 2023 | Research | $336,643 | 79 |
| 2022 | Research | $418,152 | 62 |
| 2021 | Research | $613,712 | 93 |
| 2020 | Research | $1,112,680 | 180 |
| 2019 | Research | $1,298,485 | 156 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Eric Haura Tampa, FL Named on 72 payments
- Misako Nagasaka Detroit, MI Named on 60 payments
- Dwight Owen Columbus, OH Named on 41 payments
- Elaine Shum New York, NY Named on 37 payments
- Justin Blasberg New Haven, CT Named on 27 payments
- Saiama Waqar Saint Louis, MO Named on 25 payments
- David Finley Lebanon, NH Named on 23 payments
- Ciaran McNamee Boston, MA Named on 19 payments
- Edward Garon Los Angeles, CA Named on 14 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.